The global landscape of scientific publications involving international collaboration in drug discovery displays significant variation by country. Luxembourg leads with the highest percentage of 84.4%, indicating a strong international collaborative approach. European nations such as Cyprus, Iceland, and Finland also rank highly, showcasing their commitment to cross-border research efforts. Conversely, major economies like the United States and China report lower collaboration percentages of 31.65% and 10.93%, respectively, reflecting a more domestic-focused research strategy.
The following future trends are noteworthy:
- Increasing global interconnectedness is likely to spur greater international collaborations, especially in emerging economies.
- Technological advancements and platforms facilitating remote collaboration could further bridge geographic gaps in research.
- The role of international partnerships in drug discovery is expected to grow, driven by the complexity of new medical challenges and the need for diverse expertise.
Top countries in Share of Scientific Publications Involving International Collaboration in Drug Discovery by Country
| # | 10 Countries | Percent | Last Year | |
|---|---|---|---|---|
| 1 | 1 Luxembourg | 84.4 | 2023 | View data |
| 2 | 2 Cyprus | 77.14 | 2023 | View data |
| 3 | 3 Iceland | 75.63 | 2023 | View data |
| 4 | 4 Saudi Arabia | 71.09 | 2023 | View data |
| 5 | 5 United Arab Emirates | 67.55 | 2023 | View data |
| 6 | 6 Malta | 67.48 | 2023 | View data |
| 7 | 7 Finland | 65.82 | 2023 | View data |
| 8 | 8 Sweden | 65.19 | 2023 | View data |
| 9 | 9 Belgium | 60.37 | 2023 | View data |
| 10 | 10 Netherlands | 57.38 | 2023 | View data |
